Skip to main content
SpringerLink
Log in
Book cover

Urolithiasis pp 381–410Cite as

Modern Stone Science

  • Chapter
  • First Online:

  • 1143 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Osler W. Sir William Osler 1849–1919 a selection for medical students. In: Roland CG, editor. Toronto: The Hannah Institute for the History of Medicine; 1982. p. 103–14.

    Google Scholar 

  2. Preminger G. International Urolithiasis Society. Urol Res. 2004;32:177–80.

    Google Scholar 

  3. Bichler KH. Thirty-eight years of stone meetings in Europe. Urol Res. 2006;34:70–80.

    CAS  PubMed  Google Scholar 

  4. Newton I. The correspondence of Isaac Newton, vol. 1. In: Turnbull HW, editor. Cambridge: University Press; 1959. p. 416.

    Google Scholar 

  5. Hodgkinson A, Nordin BEC, editors. Proceedings of the renal stone research symposium. London: J & A Churchill; 1968.

    Google Scholar 

  6. Hesse A, Robertson WG. Report on the Fifth Jena urinary stone symposium 16th–17th September 1977. Urol Res. 1978;6:173–5.

    CAS  PubMed  Google Scholar 

  7. Drach GW, Pak CYC. History of the ROCK Society. J Endourol. 2009;23(2):183–4.

    PubMed  Google Scholar 

  8. Prien EL. Crystallography analysis of urinary calculi; a 25 year survey study. J Urol. 1963;89:917–24.

    CAS  PubMed  Google Scholar 

  9. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.

    PubMed  Google Scholar 

  10. Pearle MS, Calhoun EA, Curhan GC. Urologic diseases of America project: urolithiasis. J Urol. 2005;173(3):848–57.

    PubMed  Google Scholar 

  11. Shattock SG. An Egyptian calculus. 27. A prehistoric or predynastic Egyptian calculus. Trans Pathol Soc Lond. 1905;56:275–90.

    CAS  Google Scholar 

  12. Moran ME. Uric acid stone disease. Front Biosci. 2003;8:1339–55.

    Google Scholar 

  13. Hall MP. Paracelsus his mystical and medical philosophy. Los Angeles: The Philosophical Research Society; 1964.

    Google Scholar 

  14. Sydenham T. The works of Thomas Sydenham (Latham RG, Trans.). London: Sydenham Society; 1848.

    Google Scholar 

  15. Osler W. Principles and practice of medicine. New York, NY: D. Appleton and Co.; 1892. p765.

    Google Scholar 

  16. Pearson G. Experiments and observations, tending to show the composition and properties of urinary concretions. Philos Trans R Soc Lond. 1798;88:15–46.

    Google Scholar 

  17. Richet G. The chemistry of urinary stones around 1800: a first in clinical chemistry. Kidney Int. 1995;48:876–86.

    CAS  PubMed  Google Scholar 

  18. Wollaston WH. On gouty and urinary concretions. Philos Trans R Soc Lond. 1797;87:386–400.

    Google Scholar 

  19. Marcet A. An essay on the chemical history and medical treatment of calculous disorders. London: Longman, Hurst, Rees, Orme, and Brown; 1817.

    Google Scholar 

  20. Shattock SG. On the microscopic structure of uric acid calculi. Philos Trans R Soc Lond 1908;110–46.

    Google Scholar 

  21. Finlayson B, Smith A. Stability of first dissociable proton of uric acid. J Chem Engin Data. 1994;19:94–7.

    Google Scholar 

  22. Coe FL, Strauss AL, Tembe V, Le Dun S. Uric acid saturation in calcium nephrolithiasis. Kidney Int. 2000;17(5):662–8.

    Google Scholar 

  23. Coe RL, Moran E, Kavalach AG. The contribution of dietary purine over-consumption to hyperuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976;29:793–800.

    CAS  PubMed  Google Scholar 

  24. Zollner N, Griebsch A. Diet and gout. Adv Exp Med Biol. 1974;41:435–42.

    CAS  PubMed  Google Scholar 

  25. Wortmann RL, Fox IH. Limited value of uric acid to creatinine ratios in estimating uric acid excretion. Ann Intern Med. 1980;93:822–5.

    CAS  PubMed  Google Scholar 

  26. Yamakita J, Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Hada T. Effect of urine storage on urinary uric acid concentrations. Ann Clin Biochem. 2000;37:355–9.

    CAS  PubMed  Google Scholar 

  27. Hesse A, Siener R, Heynck A, Jahren A. The influence of dietary factors on the risk or urinary stone formation. Scanning Microsc. 1993;7:1119–27.

    CAS  PubMed  Google Scholar 

  28. Pak CYC, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol. 2001;165(2):378–81.

    CAS  PubMed  Google Scholar 

  29. Faller J, Fox IH. Ethanol induced alterations in uric acid metabolism. Adv Exp Med Biol. 1984;165:457–62.

    PubMed  Google Scholar 

  30. Raivo KO, Becker MA, Meyer W, Greene ML, Nuki G, Seegmiller JE. Stimulation of human purine synthesis de novo by fructose infusion. Metabolism. 1975;24:861–9.

    Google Scholar 

  31. Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47:929–33.

    CAS  PubMed  Google Scholar 

  32. Sorensen LB, Levinson DS. Origin and extrarenal elimination of uric acid in men. Nephron. 1975;14:7–20.

    CAS  PubMed  Google Scholar 

  33. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in Type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol. 2006;17:1422–8.

    CAS  PubMed  Google Scholar 

  34. Knoll T. Epidemiology, pathogenesis, and pathophysiology of urolithiasis. EAU Supp. 2010;9:802–6.

    CAS  Google Scholar 

  35. Meyer JL, Bergert JH, Smith LH. Epitaxial relationships in urolithiasis: the brushite-whewellite system. Clin Sci Mol Med. 1977;52(2):143–8.

    CAS  PubMed  Google Scholar 

  36. Stokes JM. The osmotic and activity coefficients of sodium and potassium dihydrogen phosphate at 25°C. Trans Faraday Soc. 1945;41:685.

    CAS  Google Scholar 

  37. Vermeulen CW, Lyon ES, Miller GH. Calcium phosphate solubility in urine as measured by a precipitation test: experimental urolithiasis. XIII. J Urol. 1958;79(3):596–606.

    CAS  PubMed  Google Scholar 

  38. Elliot JS. Calcium phosphate solubility in urine. J Urol. 1957;77(2):269–74.

    CAS  PubMed  Google Scholar 

  39. Nordin BEC, Robertson WG. Calcium phosphate and oxalate ion-products in normal and stone forming urines. Br Med J. 1966;1(5485):450–3.

    CAS  PubMed  Google Scholar 

  40. Pak CYC. Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J Clin Invest. 1969;48:1914–22.

    CAS  PubMed  Google Scholar 

  41. Pak CYC, Eanes ED, Ruskin B. Spontaneous precipitation in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate. Proc Natl Acad Sci USA. 1971;68(7):1456–60.

    CAS  PubMed  Google Scholar 

  42. Albright F, Sulkowitch HW, Chute R. Nonsurgical aspects of the kidney stone problem. JAMA. 1939;113:2049–53.

    CAS  Google Scholar 

  43. Burnett CH, Commons RR, Albright F, Howard JE. Hypercalcemia without hypercalciuria or hypophosphatemia, calcinosis and renal insufficiency. N Engl J Med. 1949;240:787–94.

    CAS  PubMed  Google Scholar 

  44. Tiselius HG, Larson L. Calcium phosphate: an important crystal phase in patients with recurrent stone formation? Urol Res. 1993;21:175–80.

    CAS  PubMed  Google Scholar 

  45. Klee LW, Brito CG, Lingeman JE. The clinical implications of brushite calculi. J Urol. 1991;145:715–8.

    CAS  PubMed  Google Scholar 

  46. Mandel N, Mandel I, Fryjoff K, et al. Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol. 2003;169(6):2026–9.

    PubMed  Google Scholar 

  47. Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transpl. 2009;24:130–6.

    CAS  Google Scholar 

  48. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005;67(2):576–91.

    CAS  PubMed  Google Scholar 

  49. Pizzarelli F, Peacock M. Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. Nephron. 1987;46(3):247–52.

    CAS  PubMed  Google Scholar 

  50. Tozuka K, Yonese Y, Konjiki T, Sudo T. Study of calcium phosphate crystalluria. J Urol. 1987;138(2):326–9.

    CAS  PubMed  Google Scholar 

  51. Mandell NS, Mandell GS. Physiochemistry of urinary stone formation. In: Pak CYC, editor. Renal stone disease. Pathogenesis, prevention, and treatment. Boston, MA: Martinus Nijhoff Publishing; 1987. p. 3.

    Google Scholar 

  52. Flocks RH. Calcium and phosphorous excretion in the urine of patients with renal or ureteral calculi. JAMA. 1939;113:1466–71.

    CAS  Google Scholar 

  53. Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria. A preliminary report. Proc R Soc Med. 1953;46:1077–81.

    CAS  PubMed  Google Scholar 

  54. Pak CYC, Ohata M, Lawrence EC, Snyder W. The hypercalciurias: causes, parathyroid functions and diagnostic criteria. J Clin Invest. 1974;54(2):387–400.

    CAS  PubMed  Google Scholar 

  55. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50–9.

    CAS  PubMed  Google Scholar 

  56. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006;367:333–4.

    CAS  PubMed  Google Scholar 

  57. Kissin B, Locs OM. Urinary citrates in calcium urolithiasis. Proc Soc Exp Biol. 1941;46:216–8.

    CAS  Google Scholar 

  58. Pak CY. Citrate and renal calculi: new insights and future directions. Am J Kidney Dis. 1991;17:420–5.

    CAS  PubMed  Google Scholar 

  59. Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int. 2009;75(6):585–95.

    CAS  PubMed  Google Scholar 

  60. Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int. 2006;69(4):691–8.

    CAS  PubMed  Google Scholar 

  61. Milliner D. Treatment of the primary hyperoxalurias: a new chapter. Kidney Int. 2006;70:1198–200.

    CAS  PubMed  Google Scholar 

  62. Reynolds TB. Medical complications of intestinal bypass surgery. Adv Intern Med. 1978;23:47–59.

    CAS  PubMed  Google Scholar 

  63. Pak CYC, Britton F, Peterson R, Ward D, Norhcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med. 1980;69(1):19–30.

    CAS  PubMed  Google Scholar 

  64. Sella S, Cattelan C, Realdi G, Giannini S. Bone disease in primary hypercalcuria. Clin Cases Min Bone Metab. 2008;5(2):118–26.

    Google Scholar 

  65. Borghi L, Meschi T, Guerra A, Maninetti L, Pedrazzoni M, Marcato A, Vescovi P, Novarini A. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol. 1991;146(5):1334–8.

    CAS  PubMed  Google Scholar 

  66. Fournier A, Ghazali A, Bataille P, Cohen Solal M, Marie A, Brazier M, Sebert JL, Prin L. Bone involvement in idiopathic calcium-stone formers. In: Kidney stones: medical and surgical management. Lippincott-Raven, Philadelphia 1996.

    Google Scholar 

  67. National Institutes of Health Consensus Development Conference Statement. Osteoporosis. Conference Statement 5(3); 1984.

    Google Scholar 

  68. Recker RR. Continuous treatment of osteoporosis: current status. Orthop Clin NA. 1981;12:611–27.

    CAS  Google Scholar 

  69. NIH Consensus Development Panel on Optimal Calcium Intake. Optimal calcium intake. JAMA. 1994;272:1942–8.

    Google Scholar 

  70. Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med. 2002;347:983–91.

    CAS  PubMed  Google Scholar 

  71. Bataille P, Chavasad G, Gregoire I, Daigre JL, Coevoet B, Makdassi R, Pruna A, Locquiet P, Sueur JP, Fournier A. Effect of calcium restriction on renal oxalate and the probability of stones in various pathophysiological groups with calcium stones. J Urol. 1983;130(2):218–23.

    CAS  PubMed  Google Scholar 

  72. Curhan GC, Willet WC, Rimm EB, Stampeer JM. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.

    CAS  PubMed  Google Scholar 

  73. Lingeman JE, Saywell Jr RM, Woods JR, Newman DM. Cost analysis of extracorporeal shock wave lithotripsy relative to other surgical and nonsurgical treatment alternatives for urolithiasis. Med Care. 1986;24:1151–60.

    CAS  PubMed  Google Scholar 

  74. Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney Int. 1996;50:1706–12.

    CAS  PubMed  Google Scholar 

  75. Hauser G. Uber fäulnissbacterien und deren beziehungen zur septicämie. Ein betrag zur morphologie der spaltpilze. Leipzig: Vogel; 1885.

    Google Scholar 

  76. Wenner JJ, Rettger LF. A systematic study of the Proteus group of bacteria. J Bacteriol. 1919;4:331–53.

    CAS  PubMed  Google Scholar 

  77. Centers for Disease Control and Prevention. 1996. National nosocomial infections surveillance (NNIS) report, data summary October 1986–April 1996. Am J Infect Control. 1996;24:381.

    Google Scholar 

  78. Rahman NU, Meng MV, Stoller ML. Infections and urinary stone disease. Curr Pharm Des. 2003;9(12):975–81.

    CAS  PubMed  Google Scholar 

  79. Griffith DP, Musher DM, Itin C. Urease: the primary cause of infection-induced urinary stones. Invest Urol. 1976;13(5):346–50.

    CAS  PubMed  Google Scholar 

  80. Priestly JT, Dunn JH. Branched renal calculi. J Urol. 1949;61:194–203.

    Google Scholar 

  81. Vermeulen CW, Grove WJ, Goetz R, Ragins HD, Correll NO. Experimental urolithiasis. I. Development of calculi upon foreign bodies surgically introduced into bladders of rats. J Urol. 1950;64(4):541–8.

    CAS  PubMed  Google Scholar 

  82. Hellstrom J. The significance of staphylococci in the development and treatment of renal and ureteric stones. Br J Urol. 1938;10(4):348–72.

    Google Scholar 

  83. Boyce WH, Garvey FK. The amount and nature of the organic matrix in urinary calculi: a review. J Urol. 1956;76(3):213–27.

    CAS  PubMed  Google Scholar 

  84. Boyce W, King Jr J. Crystal-matrix interactions in calculi. J Urol. 1959;81:351–65.

    CAS  PubMed  Google Scholar 

  85. Boyce WH, Garvey FK, Norfleet Jr CM. Proteins and other biocolloids of urine in health and in calculous disease. I. Electrophoretic studies at pH 4.5 and 8.6 of those components soluble in molar sodium chloride. J Clin Invest. 1954;33(10):1287–97.

    CAS  PubMed  Google Scholar 

  86. Boyce WH, Swanson M. Biocolloids of urine in health and in calculous disease. II. Electrophoretic and biochemical studies of a mucoprotein insoluble in molar sodium chloride. J Clin Invest. 1955;34(10):1581–9.

    CAS  PubMed  Google Scholar 

  87. Boyce WH, Sulkin NM. Biocolloids of urine in health and in calculous disease. III. The mucoprotein matrix of urinary calculi. J Clin Invest. 1956;35(10):1067–79.

    CAS  PubMed  Google Scholar 

  88. McLean RJ, Nickel JC, Noakes VC, Costerton JW. An in vitro ultrastructural study of infectious kidney stone genesis. Infect Immun. 1985;49(3):805–11.

    CAS  PubMed  Google Scholar 

  89. Griffith DP. Struvite stones. Kidney Int. 1978;13(5):372–82.

    CAS  PubMed  Google Scholar 

  90. Nemoy NJ, Staney TA. Surgical, bacteriological, and biochemical management of "infection stones". JAMA. 1971;215(9):1470–6.

    CAS  PubMed  Google Scholar 

  91. Schlangenhufer F. Uber eigentumliche Staphylomyleosen der Nieren und des Pararenalen Bindegewebes. Frankfurt 2, Path 1916;19:139.

    Google Scholar 

  92. Malek RS, Greene LF, Deweerd JH, Farrow GM. Xanthogranulomatous pyelonephritis. BJU. 1972;44:296–308.

    CAS  PubMed  Google Scholar 

  93. Bissada NK, Holder JC, Redman JF. Preoperative diagnosis of xanthogranulomatous pyelonephritis. Urology. 1976;7(2):228–30.

    CAS  PubMed  Google Scholar 

  94. Vargas AD, Bragin SD, Mendez R. Staghorn calculi: its clinical presentation, complications and management. J Urol. 1982;127(5):860–2.

    CAS  PubMed  Google Scholar 

  95. Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol. 1976;115(5):505–6.

    CAS  PubMed  Google Scholar 

  96. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso Jr JN, McCullough DL. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. 1994;151(6):1648–51.

    CAS  PubMed  Google Scholar 

  97. Gambaro G, Favaro S, D’Angelo A. Risk for renal failure in nephrolithiasis. Am J Kidney Dis. 2001;37(2):233–43.

    CAS  PubMed  Google Scholar 

  98. Loewy A, Neuberg C. Über Cystinurie. Zschr Physiol Chem. 1904;43:338–54.

    CAS  Google Scholar 

  99. Wollaston WH. On cystic oxide, a new species of urinary calculus. Philos Trans R Soc Lond. 1810;100:223–30.

    Google Scholar 

  100. Vassar GJ, Chan KF, Teichman JM, Glickman RD, Weintraub ST, Pfefer TJ, Welch AJ. Holmium:YAG lithotripsy: photothermal mechanism. J Endourol. 1999;13(3):181–90.

    CAS  PubMed  Google Scholar 

  101. Garrod AE. Inborn errors of metabolism. II. Lancet. 1908;2:73–9.

    CAS  Google Scholar 

  102. Knox EW. Sir Archibald Garrod’s “Inborn Errors of Metabolism.” I. Cystinuria. Am J Hum Genet. 1958;10(1):3–32.

    CAS  PubMed  Google Scholar 

  103. Niemann A. Beitrag zur Lehre von Cystinurie beim Menschen. Deut Arch klin Med. 1876;18:232–63.

    Google Scholar 

  104. Mendell G. Versuche über Pflanzen Hybriden. Verhand nature Vareins Brünn 1866 English transl. J R Hortic Soc 1901;26:1–32.

    Google Scholar 

  105. Simon CE. Cystinuria and its relation to diaminuria. Am J Med Sci. 1900;119:63–93.

    Google Scholar 

  106. Garrod A. Inborn errors of metabolism. London: Henry Frowde and Hodder & Stoughton; 1923.

    Google Scholar 

  107. Engel R. Lithotomists at the dawn of the United States. De Historia Urologiae Europaeae. 2011;18:173–87.

    Google Scholar 

  108. Friedmann E. Der Kreislauf des Schwefels in der organischen Natur. Erg Physiol. 1902;1:15–31.

    Google Scholar 

  109. Mörner KAH. Cystin, ein Spaltungsprodukt der Hornsubstanz. Zschr physiol Chem. 1899;28:595–615.

    Google Scholar 

  110. Thiele FH. Concerning cystinuria and diamines. J Physiol. 1907;36:68–80.

    CAS  PubMed  Google Scholar 

  111. Brand E, Cahill GF, Harris MM. Cystinuria. II. The metabolism of cystine, cysteine, methionine, and glutathione. J Biol Chem. 1935;109:69–83.

    CAS  Google Scholar 

  112. Lassaigne JL. Observation sur l’Existence de l’Oxide cystique dans un Calcul vesical du Chien, et Essai analytique sur la Composition elementaire de cette Substance particuliere. Ann de chim et phys. 1823;23:328–34.

    Google Scholar 

  113. Yen HL, Frankl W, Dunn MS, Parker P, Hughes B, György P. The urinary excretion of amino acids by a cystanuric subject. Am J Med Sci. 1947;214:507–12.

    Google Scholar 

  114. Stein WH. Excretion of amino acids in cystinuria. Proc Soc Exper Biol. 1951;78:705–8.

    CAS  Google Scholar 

  115. Dent CE, Harris H. The genetics of ‘cystinuria’. Ann Eugen. 1951;16:60–87.

    Google Scholar 

  116. Dent CE, Senior B, Walshe JM. The pathogenesis of cystinuria. II. Polarographic studies of the metabolism of sulfur-containing amino acids. J Clin Inves. 1954;33:1216–26.

    CAS  Google Scholar 

  117. Harris H, Mittwoch U, Robson EB, Warren FL. Phenotypes and genotypes in cystinuria. Ann Human Genet. 1955;20:57–91.

    CAS  Google Scholar 

  118. Arrow VK, Westall RG. Amino acid clearances in cystinuria. J Physiol. 1958;142(1):141–6.

    CAS  PubMed  Google Scholar 

  119. Neil MW. The absorption of cystine and cysteine from the rat small intestine. Biochem J. 1959;71(1):118–24.

    CAS  PubMed  Google Scholar 

  120. Brigham MP, Stein WH, Moore S. The concentrations of cysteine and cystine in human blood plasma. J Clin Invest. 1960;39(11):1633–8.

    CAS  PubMed  Google Scholar 

  121. Rosenberg LE, Downing JL, Holland JM. Intestinal absorption and renal extraction of cystine and cysteine in cystinuria. N Engl J Med. 1965;273:1239–45.

    CAS  PubMed  Google Scholar 

  122. Rosenberg LE, Crawhall JC, Segal S. Intestinal transport of cystine and cysteine in man: evidence for separate mechanism. J Clin Invest. 1967;46(1):30–4.

    CAS  PubMed  Google Scholar 

  123. Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, De Perna M, de Sanctis L, Rousaud F, Zelante L, Palacin M, Nunes V. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet. 2005;42:58–68.

    CAS  PubMed  Google Scholar 

  124. Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL. Clinical use of cystine supersaturation measurements. J Urol. 2000;164(5):1481–5.

    CAS  PubMed  Google Scholar 

  125. Sakhaee K, Poindexter JR, Pak CY. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. J Urol. 1984;141(4):819–21.

    Google Scholar 

  126. Crawhall SE, Scowen EF, Watts RW. Effect of penicillamine on cystinuria. Br Med J. 1963;1(5330):588–90.

    CAS  PubMed  Google Scholar 

  127. Pak CY, Fuller C, Sakhaee K, Zerwekh JE, Adams BV. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986;136(5):1003–8.

    CAS  PubMed  Google Scholar 

  128. Horwitz LD. Bucillamine: a potent thiol donor with multiple clinical applications. Cardiovasc Drug Rev. 2003;21(2):77–90.

    CAS  PubMed  Google Scholar 

  129. Randall A. An hypothesis for the origin of renal calculus. N Engl J Med. 1936;214:234–42.

    Google Scholar 

  130. Paul HE. Bone suppuration the basic cause of renal calculus in twenty cases following war wounds. Can Med Assoc J. 1922;12(9):638–43.

    CAS  PubMed  Google Scholar 

  131. Pyrah LN, Fowweather FS. Urinary calculi developing in recumbent patients. Br J Surg. 1938;26(101):98–112.

    Google Scholar 

  132. Pulvertaft RG. Nephrolithiasis occurring in recumbency. J Bone Joint Surg. 1939;21:559–75.

    Google Scholar 

  133. Deitrick JE, Wheden GD, Shorr E. Effect of immobilization upon various metabolic and physiologic functions in normal men. Bull N Y Acad Med. 1948;24(6):364–75.

    CAS  PubMed  Google Scholar 

  134. Smith PH, Cook JB, Roberston WG. Stone formation in paraplegia. Paraplegia. 1969;7:77–85.

    CAS  PubMed  Google Scholar 

  135. Elliot JS, Todd HE. Calculus disease in patients with poliomyelitis. J Urol. 1961;86(11):484–8.

    CAS  PubMed  Google Scholar 

  136. Gallacher SJ, Ralston SH, Dryburgh FJ, Logue FL, Allam BF, Boyce BF, Boyle IT. Immobilization-related hypercalcemia- a possible novel mechanism and response to pamidronate. Postgrad Med J. 1990;66:918–22.

    CAS  PubMed  Google Scholar 

  137. Gordon DL, Reinstein L. Rehabilitation of the trauma patient. Am Surg. 1979;45:223–7.

    CAS  PubMed  Google Scholar 

  138. Slemenda CW, Reister TK, Hui SL, Miller JZ, Christian JC, Johnston Jr CC. Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity. J Pediatr. 1994;125:201–7.

    CAS  PubMed  Google Scholar 

  139. Weaver CM. Calcium requirements of physically active people. Am J Clin Nutr. 2000;72:579S–84.

    CAS  PubMed  Google Scholar 

  140. Lindahl WW, Bargen JA. Nephrolithiasis complicating chronic ulcerative colitis after ileostomy. J Urol. 1941;46:183–92.

    Google Scholar 

  141. Worcester EM. Stones due to bowel disease. In: Coe FL, Favus MJ, Pak CYC, Park JH, Preminger GM, editors. Kidney stones: medical and surgical management. Philadelphia, PA: Lippincott-Raven Publishers; 1996. p. 883–5.

    Google Scholar 

  142. Deren JJ, Porush JG, Levitt MF, Khilani MT. Nephrolithiasis as a complication of ulcerative colitis and regional enteritis. Ann Intern Med. 1962;56:843–53.

    CAS  PubMed  Google Scholar 

  143. Grossman MS, Nugent FW. Urolithiasis as a complication of chronic diarrheal disease. Am J Digest Dis. 1967;12:491–8.

    CAS  PubMed  Google Scholar 

  144. Glezayd EA, Breuer RI, Kirsner JB. Nephrolithiasis in inflammatory bowel disease. Am J Digest Dis. 1968;13:1027–34.

    Google Scholar 

  145. Harrell GT, Fisher S. Blood chemical changes in Boeck’s sarcoid with particular reference to protein, calcium and phosphatase values. J Clin Invest. 1939;18:678–93.

    Google Scholar 

  146. Henneman PH, Dempsey EF, Carol EL, Albright F. The causes of hypercalcemia in sarcoidosis and its treatment with cortisone and sodium phytate. J Clin Invest. 1956;35(11):1229–42.

    CAS  PubMed  Google Scholar 

  147. Taylor RL, Lynch Jr JJ, Winsor WG. Seasonal influence of sunlight on the hypercalcemia in sarcoidosis. Clin Res. 1963;11:220–5.

    Google Scholar 

  148. Adams J, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxy vitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invesy. 1983;72(5):1856–60.

    CAS  Google Scholar 

  149. Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax. 1995;50:555–9.

    CAS  PubMed  Google Scholar 

  150. Muther R, McCarron D, Bennett W. Renal manifestation of sarcoidosis. Arch Intern Med. 1981;141:643–5.

    CAS  PubMed  Google Scholar 

  151. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109:535–9.

    CAS  PubMed  Google Scholar 

  152. Zerwekh JE, Pak CYC, Kaplan RA, McGuire JL, Upchurch K, Breslau N, Johnson Jr R. Pathogenetic role of 1α,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endoc Metab. 1980;51:381–6.

    CAS  Google Scholar 

  153. Maierhoger W, Gray RW, Lemann Jr J. Phosphate deprivation increases serum 1,25 (OH)2-vitamin D concentrations in healthy men. Kidney Int. 1984;25(3):571–5.

    Google Scholar 

  154. Haddad JG. Vitamin D- solar rays, the milky way, or both? N Engl J Med. 1992;326:1213–5.

    CAS  PubMed  Google Scholar 

  155. Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW. Hypervitaminosis D associated with drinking milk. N Engl J Med. 1992;326:1173–7.

    CAS  PubMed  Google Scholar 

  156. Holick MF, Shao Q, Liu WW, Chen TC. The vitamin D content in fortified milk and infant formula. N Engl J Med. 1992;326:1178–81.

    CAS  PubMed  Google Scholar 

  157. Allen SH, Shah JH. Calcinosis and metastatic calcification due to vitamin D intoxication. Horm Res. 1992;37(1–2):68–77.

    CAS  PubMed  Google Scholar 

  158. Stamp TC. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva. Curr Med Res Opin. 1981;7:316–36.

    CAS  PubMed  Google Scholar 

  159. Ichioka K, Moroi S, Yamamoto S, Kamoto T, Okuno H, Terai A, et al. A case of urolithiasis due to vitamin D intoxication in a patient with idiopathic hypoparathyroidism. Acta Urolog Jpn. 2002;48:231–4.

    Google Scholar 

  160. Sato K, Emoto N, Toraya S, Tsushima T, Demura H, Tsuki N, Inaba S, Takeuchi A, Kobayashi T. Progressively increased serum 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2 intoxication. Endoc J. 1994;41:329–37.

    CAS  Google Scholar 

  161. Vermeulen CW, Lyon ES, Ellis JE, Borden TA. The renal papilla and calculogenesis. J Urol. 1967;97(4):573–82.

    CAS  PubMed  Google Scholar 

  162. Prien EL. The riddle of Randall’s plaques. J Urol. 1975;114(4):500–7.

    CAS  PubMed  Google Scholar 

  163. Bruwer A. Primary renal calculi: Anderson-Carr-Randall progression? Am J Radiol. 1979;132(5):751–8.

    CAS  Google Scholar 

  164. Khan SR, Finlayson B, Hackett RL. Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla. Am J Pathol. 1982;107:59–69.

    CAS  PubMed  Google Scholar 

  165. Stoller ML, Low RK, Shami GS, McCormick VD, Kerschmann RL. High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol. 1996;156(4):1263–6.

    CAS  PubMed  Google Scholar 

  166. Low RK, Stoller ML. Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol. 1997;158(6):2062–4.

    CAS  PubMed  Google Scholar 

  167. Renal Stone Disease. In: Evan AP, Lingeman JE, Williams Jr. JC, editors. 1st Annual international urolithiasis research symposium. Melville, NY: American Institute of Physics; 2007.

    Google Scholar 

  168. Kumar V, Farell G, Yu S, Harrington S, Firzpatrick L, Rzewuska E, Miller VM, Lieske JC. Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Invest Med. 2006;54:412–24.

    CAS  Google Scholar 

  169. Evan AP, Lingeman JE, Coe FL. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003;111:602–5.

    Google Scholar 

  170. Edelson E. Gregor Mendel and the roots of genetics. Oxford: Oxford University Press; 1999.

    Google Scholar 

  171. Haekel E. Anthropogenie oder Entwickelungsgeschichte des Menschen. 3rd ed. Leipzig: Wilhelm Engelmann; 1877.

    Google Scholar 

  172. Flemming W. Zur Kenntniss der Zelle und ihrer Theilungs-Erscheinungen. Natur Vereins Schles-Holst. 1878;3:23–7.

    Google Scholar 

  173. Sutton WS. The chromosomes in heredity. Biol Bull. 1903;4:231–51.

    Google Scholar 

  174. Jacob F. The logic of life. A history of heredity. New York, NY: Pantheon Books; 1973.

    Google Scholar 

  175. Prasad C, Galbraith PA. Sir Archibald Garrod and alkaptonuria- ‘story of metabolic genetics’. Clin Genet. 2005;68(3):199–203.

    CAS  PubMed  Google Scholar 

  176. Watson JD, Crick FHC. A structure for deoxyribose nucleic acid. Nature. 1953;171:737–8.

    CAS  PubMed  Google Scholar 

  177. Watson JD. The double helix. New York, NY: Simon & Schuster; 1968.

    Google Scholar 

  178. National Institute of Health: Human Genome Project. http://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=45

  179. Coe FL, Parks JH, Moore ES. Familial idiopathic hypercalciuria. N Engl J Med. 1979;300:337–40.

    CAS  PubMed  Google Scholar 

  180. Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol. 2005;16:729–45.

    PubMed  Google Scholar 

  181. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598–608.

    CAS  PubMed  Google Scholar 

  182. National Institutes of Health: Rat Genome Database. http://www.nhlbi.nih.gov/resources/res-databases/rgd.htm

  183. Goldfarb DS, Fischer ME, Keich Y, Goldfarb J. A twin nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005;67:1053–61.

    PubMed  Google Scholar 

  184. de Chardin PT. The future of man. New York, NY: Random House; 2004.

    Google Scholar 

  185. Van Beverwijck J. Treatise on the stone showing the origin, symptoms, occurrence, prevention and treatment of stone and gravel (Schipper JJ, English Trans.). Amsterdam; 1652.

    Google Scholar 

  186. Wyman AJ, Webb MA. Calcium oxalate accumulation in Malpighian tubules of silkworm (Bombyx mori). In: Evan AP, Lingeman JE, Williams Jr. JC, editors. Renal stone disease. 1st Annual international urolithiasis research symposium. Melville, NY: American Institute of Physics; 2007.

    Google Scholar 

  187. Knauf F, Preisig PA. Drosophila: a fruitful model for calcium oxalate nephrolithiasis? Kidney Int. 2011;80:327–9.

    CAS  PubMed  Google Scholar 

  188. Beutel RG, Friedrich F, Leschen RA. Charles Darwin, beetles and phylogenetics. Naturewiss. 2009;96(11):1293–312.

    CAS  Google Scholar 

  189. Darwin C. A monograph on the sub-class Cirripedia, with figures of all the species. London: Ray Society; 1852.

    Google Scholar 

  190. Okano K, Shimizu K, Satuito SG, Fusetani N. Visualization of cement exocytosis in the Cypris cement gland of the barnacle Megabalanus rosa. Exp Biol. 1996;199:2131–7.

    Google Scholar 

  191. O’Donnell MJ. Mechanisms of excretion and ion transport in invertebrates. Am Phys Soc. 1997; Suppl 30.

    Google Scholar 

  192. Novak TE, Trock BJ, Lakshmanan Y, Gearhart JP, Matlaga BR. Gender distribution of pediatric stone formers. In: Evan AP, Lingeman JE, McAteer JA, Williams Jr. JC, ediors. Renal stone disease 2, 2nd International urolithiasis research symposium. Melville, NY: American Institute Physics; 2008. p. 338–41.

    Google Scholar 

  193. Bergsland KJ, Coe FL, White MD, Erhard MJ, DeFoor WR, Mahan JD, Schwaderer AL, Asplin JR. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012;81(11):1140–8.

    CAS  PubMed  Google Scholar 

  194. Demontiero O, Herrmann M, Duque G. Supplementation with Vitamin D and calcium in long-term care residents. J Am Med Dir Assoc. 2011;12(3):190–4.

    PubMed  Google Scholar 

  195. Gentle DL, Stoller ML, Bruce JE, Leslie SW. Geriatric urolithiasis. J Urol. 1997;158(6):2221–4.

    CAS  PubMed  Google Scholar 

  196. Usui Y, Matsuzaki S, Matsushita K, Shima M. Urolithiasis in geriatric patients. Tokai J Exp Clin Med. 2003;28(2):81–7.

    PubMed  Google Scholar 

  197. Dzeranov NK, Baibarin KA, Kazachenko AV. Quality of life of elderly patients with nephrolithiasis. Urologiia. 2006;1(7):7–11.

    PubMed  Google Scholar 

  198. McKay DS, Gibson Jr EK, Thomas-Keptra KL, Vali H, Romanek CS, Clemett SJ, Chillier XDF, Maechling CR, Zare RN. Search for past life on Mars: possible relic biogenic activity in Martian Meteorite ALH84001. Science. 1996;273:924–30.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. American Urological Association, William P. Didusch Center for Urologic History, Linthicum, MD, USA

    Michael E. Moran MD

Authors
  1. Michael E. Moran MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Moran, M.E. (2014). Modern Stone Science. In: Urolithiasis. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8196-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8196-6_29

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8195-9

  • Online ISBN: 978-1-4614-8196-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation